DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,181,406 | -21.6% | 101,497 | -24.2% | 0.22% | -9.0% |
Q2 2023 | $32,128,080 | -8.2% | 133,867 | -3.6% | 0.24% | -28.2% |
Q1 2023 | $35,002,559 | -58.0% | 138,877 | -55.7% | 0.34% | -59.3% |
Q4 2022 | $83,260,661 | +59.1% | 313,694 | +54.8% | 0.84% | -4.6% |
Q3 2022 | $52,333,000 | +69.5% | 202,612 | +66.4% | 0.88% | +145.4% |
Q2 2022 | $30,871,000 | -33.8% | 121,770 | -23.4% | 0.36% | -24.0% |
Q1 2022 | $46,628,000 | +70.7% | 158,960 | +91.5% | 0.47% | +92.6% |
Q4 2021 | $27,310,000 | +0.2% | 83,006 | -7.3% | 0.24% | -30.3% |
Q3 2021 | $27,267,000 | +90.4% | 89,563 | +67.8% | 0.35% | +53.5% |
Q2 2021 | $14,319,000 | +42.7% | 53,359 | +19.7% | 0.23% | +9.6% |
Q1 2021 | $10,031,000 | -6.1% | 44,567 | -7.3% | 0.21% | -12.6% |
Q4 2020 | $10,682,000 | +133.7% | 48,085 | +126.6% | 0.24% | +26.6% |
Q3 2020 | $4,570,000 | +105.6% | 21,222 | +68.8% | 0.19% | +95.8% |
Q2 2020 | $2,223,000 | -15.2% | 12,571 | -33.7% | 0.10% | -14.3% |
Q1 2020 | $2,623,000 | -62.8% | 18,948 | -58.7% | 0.11% | -47.7% |
Q4 2019 | $7,049,000 | -5.2% | 45,928 | -10.8% | 0.21% | +13.2% |
Q3 2019 | $7,434,000 | -49.2% | 51,474 | -49.7% | 0.19% | -25.9% |
Q2 2019 | $14,622,000 | +959.6% | 102,306 | +878.4% | 0.26% | +750.0% |
Q1 2019 | $1,380,000 | -82.1% | 10,456 | -86.0% | 0.03% | -82.0% |
Q4 2018 | $7,714,000 | +23.5% | 74,806 | +30.1% | 0.17% | +54.6% |
Q3 2018 | $6,247,000 | -15.2% | 57,493 | -23.0% | 0.11% | -23.4% |
Q2 2018 | $7,367,000 | +2.3% | 74,660 | +1.6% | 0.14% | +8.5% |
Q1 2018 | $7,198,000 | +15.7% | 73,515 | +9.7% | 0.13% | +25.0% |
Q4 2017 | $6,221,000 | +2.8% | 67,018 | -5.0% | 0.10% | -11.1% |
Q3 2017 | $6,050,000 | +39.8% | 70,533 | +37.5% | 0.12% | +41.0% |
Q2 2017 | $4,328,000 | -69.9% | 51,285 | -69.5% | 0.08% | -68.2% |
Q1 2017 | $14,382,000 | +274.6% | 168,151 | +242.6% | 0.26% | +262.5% |
Q4 2016 | $3,839,000 | +36.2% | 49,080 | +34.3% | 0.07% | +111.8% |
Q3 2016 | $2,819,000 | +80.0% | 36,552 | +116.7% | 0.03% | +277.8% |
Q4 2015 | $1,566,000 | +2.6% | 16,864 | -5.5% | 0.01% | +12.5% |
Q2 2015 | $1,527,000 | +12.5% | 17,851 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $1,357,000 | -36.6% | 17,851 | -34.4% | 0.01% | -27.3% |
Q2 2014 | $2,141,000 | +5.0% | 27,200 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $2,040,000 | -22.7% | 27,200 | -20.5% | 0.01% | -15.4% |
Q4 2013 | $2,639,000 | – | 34,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |